Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paliperidone ER for Acute Manic and Mixed Episodes in Bipolar I Disorder
NCT00299715Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Feb 2006
- Primary completion
- Jun 2007
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of paliperidone in bipolar I disorder, sponsored by Johnson & Johnson. Started Feb 2006; status: completed.
02
Drugs
paliperidone
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT00299715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00299715.